VIGOR Study Issues

• Generalizability of GI findings

  • to patients on ASA
  • to NSAIDs other than naproxen

• Cardiovascular findings

  • (Statistical issues)

• Organ specific safety vs. overall safety

Previous slide

Next slide

Back to first slide

View graphic version